Recent work undertaken using specific antibodies to APOE suggests that APOE might compete with clearance mechanisms for Aβ at the BBB, and suggests potential novel targets for therapeutic intervention to reduce amyloidosis [66], [67]. Here, APOE is linked to amyloidosis.